SRI International
- Biotech or pharma, therapeutic R&D
- Medical device or technology
- Digital health
SRI, a non profit research institute seeks commercial partners with biotech & pharmaceutical companies in areas of cardiovascular, metabolic, oncology, I/O , neurological, musculoskeletal, inflammatory disease, chronic/rare diseases, precision medicine, diagnostics/sensors, and animal health.
Our focus is novel, first in class platforms with broad based applications. A high priority area is delivery of bio-therapeutic cargos: nucleic acids, antibodies, or proteins—SRI’s FOX Three™ intracellular delivery platform provides a powerful solution.
As a non-profit institute, we rely on commercial partnerships to move our platforms and programs into the market through research collaborations and license/option deals. We are actively seeking new collaborative partnerships/out-licensing partners.
SRI International founded by Stanford University (1946), has grown into a leading center for deep science innovation and translational R&D, with a legacy of pioneering technologies.
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}